trial · primary record
Selegiline Transdermal Delivery System
Major Depressive Disorder (MDD)
| Phase | Phase 1 |
|---|---|
| Status | COMPLETED |
| Sponsor | Unknown |
| Enrolment | 232 |
| Primary completion | 2026-09-26 |
| Primary endpoint | Assessment of irritation |
| Registry ID | NCT07452692 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:56:17.227Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07452692
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.